Skip to main content
Premium Trial:

Request an Annual Quote

Veritas Genetics to Offer Sequencing Services in Brazil Through Genomika

NEW YORK — Veritas Intercontinental said today that it has signed an agreement to offer its whole-genome and exome sequencing services in Brazil through Recife-based genetic testing lab Genomika.

According to Veritas Intercontinental, the international subsidiary of Danvers, Massachusetts-based Veritas Genetics, the deal includes genome and exome sequencing, analysis, and interpretation services, as well as training and support to Genomika employees providing genetic counseling to end users.

Additional terms were not disclosed.

"This agreement will speed up access for the general public to complete genome sequencing … in Brazil," Veritas Intercontinental CEO Javier de Echevarría said in a statement.

Veritas' direct-to-consumer genetic testing products include the myGenome Standard whole-genome sequencing service, as well as the recently launched myGenome Premium and myGenome Diagnostic services.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.